A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease
Study sponsor: Kiniksa Pharmaceuticals International, plc · KNSA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2025-03-06Actual
Enrollment · participants3Actual
Source updated2025-05-21Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.